| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.13e-05 | 29 | 97 | 4 | GO:0035325 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 3.89e-05 | 14 | 97 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.31e-04 | 230 | 97 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.83e-04 | 23 | 97 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | interleukin-2 receptor binding | 2.31e-04 | 5 | 97 | 2 | GO:0005134 | |
| GeneOntologyMolecularFunction | filamin binding | 3.70e-04 | 29 | 97 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 4.41e-04 | 73 | 97 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 5.96e-04 | 34 | 97 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 9.71e-04 | 90 | 97 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine kinase activity | 1.02e-03 | 10 | 97 | 2 | GO:0009931 | |
| GeneOntologyMolecularFunction | protein domain specific binding | HAP1 INPP5A GATA3 MED1 FOXA3 HOXB1 NCOR1 TRPV4 AFDN QKI LILRB5 UNC13A | 1.08e-03 | 875 | 97 | 12 | GO:0019904 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CEACAM5 PCDHGB5 PCDHGB3 PSG4 PSG5 PCDH11Y PCDHGB4 CDH8 CDH11 CDH18 | 2.07e-08 | 187 | 98 | 10 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CEACAM5 PCDHGB5 PCDHGB3 PSG4 PSG5 PCDH11Y PCDHGB4 CDH8 CDH11 CDH18 | 2.42e-06 | 313 | 98 | 10 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 2.64e-06 | 246 | 98 | 9 | GO:0045216 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | CEACAM5 PSG4 PSG5 GATA3 ACVR1B CUBN MED1 FOXA3 NCOR1 UBAP2L CD36 PRKCA TRPV4 AFDN QKI USH2A LILRB5 | 7.70e-06 | 1043 | 98 | 17 | GO:0048871 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | MAGI1 ZC3H12A CEACAM5 PCDHGB5 PCDHGB3 PSG4 PSG5 PCDH11Y GATA3 CYFIP2 PCDHGB4 PRKCA TRPV4 AFDN CDH8 CDH11 CDH18 | 1.17e-05 | 1077 | 98 | 17 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of miRNA catabolic process | 1.67e-05 | 11 | 98 | 3 | GO:2000625 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 2.24e-05 | 35 | 98 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | ADAMTS19 CEACAM5 IRX5 PSG4 PSG5 HYAL1 GATA3 MED1 HMX2 ZFPM2 NRP2 ESRP2 ENAM HOXB1 HOXC11 TRPV4 AFDN USH2A | 2.64e-05 | 1269 | 98 | 18 | GO:0009887 |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 3.12e-05 | 38 | 98 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 3.64e-05 | 14 | 98 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell migration | 3.84e-05 | 344 | 98 | 9 | GO:0010632 | |
| GeneOntologyBiologicalProcess | circulatory system development | ADAMTS19 ZC3H12A CEACAM5 PSG4 PSG5 HYAL1 GATA3 E2F2 ACVR1B MED1 ZFPM2 NRP2 SCUBE1 PIK3C2A CD36 PRKCA QKI DNAH5 CDH11 | 4.20e-05 | 1442 | 98 | 19 | GO:0072359 |
| GeneOntologyBiologicalProcess | regulation of endothelial cell migration | 4.31e-05 | 269 | 98 | 8 | GO:0010594 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 4.54e-05 | 15 | 98 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 4.54e-05 | 15 | 98 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 4.54e-05 | 15 | 98 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 4.54e-05 | 15 | 98 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 4.67e-05 | 42 | 98 | 4 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 5.30e-05 | 85 | 98 | 5 | GO:0002762 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 5.32e-05 | 139 | 98 | 6 | GO:0007173 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 5.57e-05 | 16 | 98 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 5.61e-05 | 86 | 98 | 5 | GO:0042058 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | ZC3H12A CEACAM5 PSG4 PSG5 HYAL1 GATA3 E2F2 MED1 ZFPM2 NRP2 ENAM HOXB1 HOXC11 PIK3C2A CD36 PRKCA RBM46 QKI CDH11 | 6.14e-05 | 1483 | 98 | 19 | GO:0048646 |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 6.71e-05 | 46 | 98 | 4 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 6.71e-05 | 46 | 98 | 4 | GO:0072574 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 6.74e-05 | 17 | 98 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 6.74e-05 | 17 | 98 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 6.74e-05 | 17 | 98 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of myeloid cell differentiation | 6.96e-05 | 288 | 98 | 8 | GO:0045637 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 8.06e-05 | 18 | 98 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 8.16e-05 | 93 | 98 | 5 | GO:1901184 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 8.43e-05 | 151 | 98 | 6 | GO:1902106 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 8.62e-05 | 49 | 98 | 4 | GO:0072576 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by cadherin | 9.33e-05 | 50 | 98 | 4 | GO:0044331 | |
| GeneOntologyBiologicalProcess | miRNA catabolic process | 1.12e-04 | 20 | 98 | 3 | GO:0010587 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.12e-04 | 20 | 98 | 3 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 1.12e-04 | 159 | 98 | 6 | GO:1903707 | |
| GeneOntologyBiologicalProcess | ERBB signaling pathway | 1.16e-04 | 160 | 98 | 6 | GO:0038127 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 1.17e-04 | 53 | 98 | 4 | GO:0016339 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.17e-04 | 53 | 98 | 4 | GO:0034110 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte differentiation | 1.21e-04 | 312 | 98 | 8 | GO:0002573 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | ZC3H12A CEACAM5 PSG4 PSG5 HYAL1 E2F2 MED1 ZFPM2 NRP2 PIK3C2A CD36 PRKCA QKI | 1.29e-04 | 817 | 98 | 13 | GO:0048514 |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.30e-04 | 21 | 98 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.30e-04 | 21 | 98 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.30e-04 | 21 | 98 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 1.32e-04 | 103 | 98 | 5 | GO:2000628 | |
| GeneOntologyBiologicalProcess | angiogenesis | ZC3H12A CEACAM5 PSG4 PSG5 HYAL1 E2F2 MED1 NRP2 PIK3C2A CD36 PRKCA QKI | 1.33e-04 | 708 | 98 | 12 | GO:0001525 |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 1.47e-04 | 167 | 98 | 6 | GO:0007043 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 1.50e-04 | 22 | 98 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation | 1.67e-04 | 514 | 98 | 10 | GO:0050678 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.72e-04 | 23 | 98 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.72e-04 | 23 | 98 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of angiogenesis | 1.76e-04 | 420 | 98 | 9 | GO:0045765 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.78e-04 | 59 | 98 | 4 | GO:0045671 | |
| GeneOntologyBiologicalProcess | endothelial cell migration | 1.82e-04 | 331 | 98 | 8 | GO:0043542 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | ZC3H12A CEACAM5 PSG4 PSG5 HYAL1 GATA3 E2F2 ENAM HOXC11 CD36 ARHGAP44 PRKCA AFDN QKI UNC13A | 1.88e-04 | 1090 | 98 | 15 | GO:0022603 |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 1.91e-04 | 60 | 98 | 4 | GO:0045922 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 1.96e-04 | 24 | 98 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 1.96e-04 | 24 | 98 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 1.96e-04 | 24 | 98 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | cell junction organization | CEACAM5 PSG4 PSG5 CYFIP2 NRP2 ARHGAP44 PRKCA TRPV4 AFDN CDH8 PDZRN3 UNC13A CDH11 CDH18 | 2.02e-04 | 974 | 98 | 14 | GO:0034330 |
| GeneOntologyBiologicalProcess | adherens junction organization | 2.03e-04 | 61 | 98 | 4 | GO:0034332 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 2.05e-04 | 337 | 98 | 8 | GO:0006898 | |
| GeneOntologyBiologicalProcess | regulation of vasculature development | 2.09e-04 | 430 | 98 | 9 | GO:1901342 | |
| GeneOntologyBiologicalProcess | epithelial cell migration | 2.17e-04 | 432 | 98 | 9 | GO:0010631 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | CEACAM5 PSG4 PSG5 HAP1 MAPKAPK2 GATA3 NEU3 CYFIP2 NRP2 EFNA4 PIK3C2A PRKCA | 2.19e-04 | 747 | 98 | 12 | GO:0007169 |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 2.22e-04 | 25 | 98 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 2.22e-04 | 25 | 98 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | epithelium migration | 2.28e-04 | 435 | 98 | 9 | GO:0090132 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 2.30e-04 | 63 | 98 | 4 | GO:0003179 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte differentiation | 2.34e-04 | 182 | 98 | 6 | GO:0002761 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | ZC3H12A CEACAM5 PSG4 PSG5 GATA3 ACVR1B MED1 PRKCA QKI LILRB5 | 2.48e-04 | 540 | 98 | 10 | GO:1903706 |
| GeneOntologyBiologicalProcess | vasculogenesis | 2.50e-04 | 118 | 98 | 5 | GO:0001570 | |
| GeneOntologyBiologicalProcess | tissue migration | 2.52e-04 | 441 | 98 | 9 | GO:0090130 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 2.60e-04 | 119 | 98 | 5 | GO:0010586 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | ZC3H12A CEACAM5 PSG4 PSG5 HYAL1 GATA3 E2F2 MED1 ZFPM2 NRP2 ESRP2 PIK3C2A CD36 PRKCA QKI | 2.65e-04 | 1125 | 98 | 15 | GO:0035239 |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 2.76e-04 | 66 | 98 | 4 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 2.80e-04 | 27 | 98 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | p38MAPK cascade | 2.92e-04 | 67 | 98 | 4 | GO:0038066 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 3.13e-04 | 28 | 98 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | myeloid cell differentiation | 3.21e-04 | 558 | 98 | 10 | GO:0030099 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 3.46e-04 | 70 | 98 | 4 | GO:0045124 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 3.47e-04 | 29 | 98 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 3.65e-04 | 71 | 98 | 4 | GO:0043114 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 3.85e-04 | 72 | 98 | 4 | GO:0032692 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell migration | 4.08e-04 | 202 | 98 | 6 | GO:0010634 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | ZC3H12A CEACAM5 PSG4 PSG5 HYAL1 GATA3 ACVR1B NRP2 PIK3C2A PRKCA | 4.18e-04 | 577 | 98 | 10 | GO:0001667 |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 4.24e-04 | 31 | 98 | 3 | GO:0010544 | |
| GeneOntologyBiologicalProcess | blood vessel development | ZC3H12A CEACAM5 PSG4 PSG5 HYAL1 E2F2 MED1 ZFPM2 NRP2 PIK3C2A CD36 PRKCA QKI | 4.47e-04 | 929 | 98 | 13 | GO:0001568 |
| GeneOntologyBiologicalProcess | negative regulation of myeloid cell differentiation | 4.50e-04 | 134 | 98 | 5 | GO:0045638 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | CEACAM5 PSG4 PSG5 HAP1 MAPKAPK2 PEG10 GATA3 NEU3 ACVR1B GDF10 CYFIP2 NRP2 EFNA4 PIK3C2A PRKCA | 4.63e-04 | 1186 | 98 | 15 | GO:0007167 |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 4.67e-04 | 32 | 98 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 4.67e-04 | 32 | 98 | 3 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 4.67e-04 | 32 | 98 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 5.12e-04 | 33 | 98 | 3 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 5.12e-04 | 33 | 98 | 3 | GO:2000252 | |
| GeneOntologyBiologicalProcess | heart valve development | 5.22e-04 | 78 | 98 | 4 | GO:0003170 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 5.59e-04 | 34 | 98 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 5.59e-04 | 34 | 98 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 5.75e-04 | 80 | 98 | 4 | GO:0046850 | |
| GeneOntologyCellularComponent | adherens junction | 6.90e-07 | 212 | 98 | 9 | GO:0005912 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 5.35e-05 | 16 | 98 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | catenin complex | 4.49e-04 | 32 | 98 | 3 | GO:0016342 | |
| GeneOntologyCellularComponent | cell-cell junction | 4.55e-04 | 591 | 98 | 10 | GO:0005911 | |
| GeneOntologyCellularComponent | apical part of cell | 4.61e-04 | 592 | 98 | 10 | GO:0045177 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 1.08e-03 | 96 | 98 | 4 | GO:0010494 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 6.07e-06 | 47 | 78 | 5 | MP:0031617 | |
| MousePheno | abnormal cellular glucose uptake | 2.19e-05 | 102 | 78 | 6 | MP:0003925 | |
| MousePheno | abnormal muscle cell glucose uptake | 3.50e-05 | 67 | 78 | 5 | MP:0004130 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 4.12e-05 | 35 | 78 | 4 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 4.61e-05 | 36 | 78 | 4 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 6.36e-05 | 39 | 78 | 4 | MP:0030022 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 1.07e-04 | 17 | 78 | 3 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 2.07e-04 | 21 | 78 | 3 | MP:0031415 | |
| MousePheno | decreased cellular glucose uptake | 2.13e-04 | 53 | 78 | 4 | MP:0003926 | |
| Domain | Cadherin_CS | 1.70e-06 | 109 | 98 | 7 | IPR020894 | |
| Domain | CADHERIN_1 | 2.16e-06 | 113 | 98 | 7 | PS00232 | |
| Domain | Cadherin | 2.16e-06 | 113 | 98 | 7 | PF00028 | |
| Domain | CADHERIN_2 | 2.29e-06 | 114 | 98 | 7 | PS50268 | |
| Domain | - | 2.29e-06 | 114 | 98 | 7 | 2.60.40.60 | |
| Domain | CA | 2.43e-06 | 115 | 98 | 7 | SM00112 | |
| Domain | Cadherin-like | 2.58e-06 | 116 | 98 | 7 | IPR015919 | |
| Domain | Cadherin | 2.89e-06 | 118 | 98 | 7 | IPR002126 | |
| Domain | CUB | 1.26e-04 | 49 | 98 | 4 | PF00431 | |
| Domain | CUB | 1.36e-04 | 50 | 98 | 4 | SM00042 | |
| Domain | - | 1.59e-04 | 52 | 98 | 4 | 2.60.120.290 | |
| Domain | CUB | 1.71e-04 | 53 | 98 | 4 | PS01180 | |
| Domain | CUB_dom | 2.27e-04 | 57 | 98 | 4 | IPR000859 | |
| Domain | Cadherin_cytoplasmic-dom | 2.96e-04 | 25 | 98 | 3 | IPR000233 | |
| Domain | Cadherin_C | 2.96e-04 | 25 | 98 | 3 | PF01049 | |
| Domain | Cadherin_2 | 3.78e-04 | 65 | 98 | 4 | PF08266 | |
| Domain | Cadherin_N | 3.78e-04 | 65 | 98 | 4 | IPR013164 | |
| Domain | Catenin_binding_dom | 4.64e-04 | 29 | 98 | 3 | IPR027397 | |
| Domain | - | 4.64e-04 | 29 | 98 | 3 | 4.10.900.10 | |
| Domain | Ig_2 | 5.88e-04 | 73 | 98 | 4 | PF13895 | |
| Domain | DHC_N1 | 7.48e-04 | 8 | 98 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 7.48e-04 | 8 | 98 | 2 | IPR013594 | |
| Domain | Cadherin_tail | 9.56e-04 | 37 | 98 | 3 | PF15974 | |
| Domain | Cadherin_CBD | 9.56e-04 | 37 | 98 | 3 | IPR031904 | |
| Domain | Homeobox_metazoa | 1.29e-03 | 90 | 98 | 4 | IPR020479 | |
| Domain | Cadherin_C | 1.39e-03 | 42 | 98 | 3 | IPR032455 | |
| Domain | Cadherin_C_2 | 1.39e-03 | 42 | 98 | 3 | PF16492 | |
| Domain | EGF_3 | 1.74e-03 | 12 | 98 | 2 | PF12947 | |
| Domain | EGF_dom | 1.74e-03 | 12 | 98 | 2 | IPR024731 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.38e-03 | 14 | 98 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.38e-03 | 14 | 98 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.38e-03 | 14 | 98 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.38e-03 | 14 | 98 | 2 | PF08393 | |
| Domain | MT | 2.38e-03 | 14 | 98 | 2 | PF12777 | |
| Domain | AAA_8 | 2.38e-03 | 14 | 98 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 2.38e-03 | 14 | 98 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.38e-03 | 14 | 98 | 2 | PF07728 | |
| Domain | DHC_fam | 2.74e-03 | 15 | 98 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.74e-03 | 15 | 98 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.74e-03 | 15 | 98 | 2 | PF03028 | |
| Domain | Homeobox_CS | 2.99e-03 | 186 | 98 | 5 | IPR017970 | |
| Domain | - | 3.77e-03 | 283 | 98 | 6 | 1.10.10.60 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 1.28e-05 | 58 | 74 | 5 | M11980 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 5.54e-05 | 40 | 74 | 4 | MM15060 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 1.08e-04 | 90 | 74 | 5 | M820 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 1.14e-04 | 48 | 74 | 4 | MM15069 | |
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 6.05e-08 | 14 | 99 | 4 | 34666041 | |
| Pubmed | A unique expression pattern of Tbx10 in the hindbrain as revealed by Tbx10(LacZ) allele. | 2.23e-07 | 5 | 99 | 3 | 20162674 | |
| Pubmed | 4.83e-06 | 12 | 99 | 3 | 22102170 | ||
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 6.27e-06 | 13 | 99 | 3 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 6.27e-06 | 13 | 99 | 3 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 6.27e-06 | 13 | 99 | 3 | 16638824 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 20044046 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 32150576 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 6265583 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 6.27e-06 | 13 | 99 | 3 | 12832451 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 6.27e-06 | 13 | 99 | 3 | 21670291 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 22162753 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 2702644 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 8380065 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 1279194 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 25724769 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 6.27e-06 | 13 | 99 | 3 | 22092845 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 11801635 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 6.27e-06 | 13 | 99 | 3 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 6.27e-06 | 13 | 99 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 6.27e-06 | 13 | 99 | 3 | 23800882 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 19285068 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 21760897 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 6.27e-06 | 13 | 99 | 3 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 6.27e-06 | 13 | 99 | 3 | 39168268 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 8402684 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 16619040 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 6.27e-06 | 13 | 99 | 3 | 8209741 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 6.27e-06 | 13 | 99 | 3 | 21949477 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 26219866 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 2133556 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 32521208 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 19406938 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 6.27e-06 | 13 | 99 | 3 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 6.27e-06 | 13 | 99 | 3 | 19358828 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 16680193 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 6.27e-06 | 13 | 99 | 3 | 34058224 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 10964771 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 32169849 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 6.27e-06 | 13 | 99 | 3 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 6.27e-06 | 13 | 99 | 3 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 6.27e-06 | 13 | 99 | 3 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 6.27e-06 | 13 | 99 | 3 | 23935487 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 15331748 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 6.27e-06 | 13 | 99 | 3 | 22406619 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 6.27e-06 | 13 | 99 | 3 | 25972571 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 19008452 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 6.27e-06 | 13 | 99 | 3 | 15220458 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 18843289 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 15207636 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 21081647 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 11133662 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 11483763 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 2164599 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 29396368 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 18003729 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 6.27e-06 | 13 | 99 | 3 | 33352461 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 38381498 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 20739537 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 6.27e-06 | 13 | 99 | 3 | 27695943 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 20404914 | ||
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 6.27e-06 | 13 | 99 | 3 | 32027621 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 6.27e-06 | 13 | 99 | 3 | 27777319 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 18848945 | ||
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 37531413 | ||
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 7.96e-06 | 14 | 99 | 3 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 7.96e-06 | 14 | 99 | 3 | 32209360 | |
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 11994468 | ||
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 11850617 | ||
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 7.96e-06 | 14 | 99 | 3 | 26196244 | |
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 8896983 | ||
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 22962327 | ||
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 17623671 | ||
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 7.96e-06 | 14 | 99 | 3 | 18794798 | |
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 23469261 | ||
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 18454175 | ||
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 22159884 | ||
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 29907459 | ||
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 36719377 | ||
| Pubmed | 7.96e-06 | 14 | 99 | 3 | 23780386 | ||
| Interaction | PCDHGB3 interactions | 5.95e-06 | 8 | 97 | 3 | int:PCDHGB3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 4.80e-05 | 298 | 99 | 6 | chr5q31 | |
| GeneFamily | CD molecules|Type II classical cadherins | 1.55e-05 | 13 | 70 | 3 | 1186 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 7.95e-04 | 11 | 70 | 2 | 1315 | |
| GeneFamily | Dyneins, axonemal | 1.94e-03 | 17 | 70 | 2 | 536 | |
| GeneFamily | Clustered protocadherins | 1.96e-03 | 64 | 70 | 3 | 20 | |
| CoexpressionAtlas | ovary | 2.09e-05 | 125 | 95 | 6 | ovary | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.14e-05 | 259 | 95 | 8 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k1_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | MAGI1 ADAMTS19 PEG10 CSMD3 ZFPM2 CYFIP2 TMEM171 SCUBE1 PIK3C2A CD36 NXF3 KCNT1 CDH18 | 5.85e-05 | 803 | 95 | 13 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.38e-07 | 193 | 98 | 7 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.43e-06 | 159 | 98 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-06 | 181 | 98 | 6 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.54e-06 | 186 | 98 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.00e-06 | 190 | 98 | 6 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.78e-06 | 196 | 98 | 6 | 847b3377f463bfded046eec63cc1b547f3dc33c1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.21e-06 | 199 | 98 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.21e-06 | 199 | 98 | 6 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.21e-06 | 199 | 98 | 6 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.91e-05 | 148 | 98 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.04e-05 | 150 | 98 | 5 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 154 | 98 | 5 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.39e-05 | 155 | 98 | 5 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 2.46e-05 | 156 | 98 | 5 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 159 | 98 | 5 | e967b557fe6ae4879d36f62c0297cbf6a2ad1ce9 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 159 | 98 | 5 | 9db971130509c62d439e0cab16588a4d994d7aa0 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.10e-05 | 81 | 98 | 4 | 8cb94dda18010b3b05e5ab72235850483013c03a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.13e-05 | 164 | 98 | 5 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | Bronchial_Biopsy-Immune-T_and_NK|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.51e-05 | 168 | 98 | 5 | 435b2f238fbb3f50427e8cdecf2220615015153c | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.71e-05 | 170 | 98 | 5 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | E12.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.82e-05 | 171 | 98 | 5 | a4d6b0f57eead11b01153688b06b2a45a3b488f2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-05 | 172 | 98 | 5 | 1bad7b19724e1b53ace7e05644215334c9f43910 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.15e-05 | 174 | 98 | 5 | d77fa525d5c87c190b4a10787b270eabd16c610f | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.50e-05 | 177 | 98 | 5 | d68132e145bd413404fdbe215b5dbe520e756e50 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 178 | 98 | 5 | 4289e435d465b7a1490d13bf05278f4ed77d69cd | |
| ToppCell | facs-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 180 | 98 | 5 | 72310baeed848f2c483ae986cd73d2fb2cca7feb | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 181 | 98 | 5 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 182 | 98 | 5 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.41e-05 | 184 | 98 | 5 | 571136c832cb8c08457744152231537aa8e8abd7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.55e-05 | 185 | 98 | 5 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.69e-05 | 186 | 98 | 5 | 2fdd0a80ad31cf017aafcf5dcf760ebd786b98c1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.69e-05 | 186 | 98 | 5 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.84e-05 | 187 | 98 | 5 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.99e-05 | 188 | 98 | 5 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-05 | 189 | 98 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-05 | 189 | 98 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.14e-05 | 189 | 98 | 5 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 190 | 98 | 5 | 8cb950effc449ae59a915132ecc079be54d1acfe | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.30e-05 | 190 | 98 | 5 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 190 | 98 | 5 | 5dfbd064ab1f8a0b18b5975c47f8e79697f3db15 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 190 | 98 | 5 | 17a73a658fb30a4322b31e38db7b240023738f29 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-05 | 190 | 98 | 5 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-05 | 191 | 98 | 5 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.45e-05 | 191 | 98 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 6.45e-05 | 191 | 98 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-05 | 191 | 98 | 5 | 4bfdf44d4402a42530d30c89d94946acdda4321b | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-05 | 191 | 98 | 5 | f0c649bb32732c9dd38a0af8ce94d2a4d16de39a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.45e-05 | 191 | 98 | 5 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-05 | 191 | 98 | 5 | e518c598719119e60c76016c586b1520c258bbcb | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.61e-05 | 192 | 98 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.61e-05 | 192 | 98 | 5 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.61e-05 | 192 | 98 | 5 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.61e-05 | 192 | 98 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.61e-05 | 192 | 98 | 5 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.78e-05 | 193 | 98 | 5 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.78e-05 | 193 | 98 | 5 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-05 | 193 | 98 | 5 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-05 | 193 | 98 | 5 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.78e-05 | 193 | 98 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | myeloid-macrophage|World / Lineage and Cell class | 6.78e-05 | 193 | 98 | 5 | b13e694123b87ed8ad1786feb996398ddd84e94b | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.78e-05 | 193 | 98 | 5 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Pro-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.95e-05 | 194 | 98 | 5 | 58d7c56d2b9c893b62da2334428d677e3451fe07 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.95e-05 | 194 | 98 | 5 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.95e-05 | 194 | 98 | 5 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | facs-Heart-LA-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 194 | 98 | 5 | 33cc4f1d716cb71d54cdedbe9bbdc0d7b17c4777 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.95e-05 | 194 | 98 | 5 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.07e-05 | 100 | 98 | 4 | c50714a0819a40917d7a360623220576473f52ad | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-05 | 196 | 98 | 5 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.29e-05 | 196 | 98 | 5 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.47e-05 | 197 | 98 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.47e-05 | 197 | 98 | 5 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.47e-05 | 197 | 98 | 5 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.47e-05 | 197 | 98 | 5 | 3a0e97bfebe82f9687d518baaad7f20d0ffea8a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.65e-05 | 198 | 98 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.83e-05 | 199 | 98 | 5 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-05 | 199 | 98 | 5 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.83e-05 | 199 | 98 | 5 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.83e-05 | 199 | 98 | 5 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 7.83e-05 | 199 | 98 | 5 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 7.83e-05 | 199 | 98 | 5 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.83e-05 | 199 | 98 | 5 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.83e-05 | 199 | 98 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 7.83e-05 | 199 | 98 | 5 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Mesoderm|1m / Sample Type, Dataset, Time_group, and Cell type. | 8.02e-05 | 200 | 98 | 5 | c0ad32e9dd7f481c2665587fd8bd9fffc2e725f9 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 98 | 5 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Spon1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.78e-04 | 127 | 98 | 4 | cd69ba386796715e87674f8324d2acaad1d4d094 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.84e-04 | 128 | 98 | 4 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 1.89e-04 | 129 | 98 | 4 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-04 | 136 | 98 | 4 | b4a934feea46eeb10d407d1545bd225173078792 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-04 | 136 | 98 | 4 | 7cd22169fb71c6caf9feb203ad98be8480a54fba | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 2.52e-04 | 139 | 98 | 4 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | AT1-AT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.96e-04 | 145 | 98 | 4 | cd5de30fd948024e3ad043c9411ce9f2722178b2 | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.12e-06 | 196 | 98 | 8 | 5058_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; ssMCF7; HG-U133A | 2.38e-06 | 199 | 98 | 8 | 373_UP | |
| Disease | level of pregnancy-specific beta-1-glycoprotein 3 in blood serum | 9.83e-06 | 2 | 93 | 2 | OBA_2043058 | |
| Disease | level of pregnancy-specific beta-1-glycoprotein 4 in blood serum | 9.83e-06 | 2 | 93 | 2 | OBA_2043059 | |
| Disease | mental development measurement | 6.63e-05 | 25 | 93 | 3 | EFO_0008230 | |
| Disease | cortical surface area measurement | ANO4 MAGI1 ADAMTS19 ATXN2L INPP5A CPA3 GDF10 RND3 HOXB1 NCOR1 SCUBE1 MTMR11 PDZRN3 CDH11 | 7.96e-05 | 1345 | 93 | 14 | EFO_0010736 |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 1.46e-04 | 6 | 93 | 2 | EFO_0801907 | |
| Disease | polycystic ovary syndrome (implicated_via_orthology) | 1.46e-04 | 6 | 93 | 2 | DOID:11612 (implicated_via_orthology) | |
| Disease | platelet glycoprotein 4 measurement | 1.46e-04 | 6 | 93 | 2 | EFO_0008262 | |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 2.04e-04 | 7 | 93 | 2 | EFO_0801906 | |
| Disease | Retinitis Pigmentosa | 3.34e-04 | 104 | 93 | 4 | C0035334 | |
| Disease | age-related hearing impairment | 5.72e-04 | 324 | 93 | 6 | EFO_0005782 | |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 8.72e-04 | 14 | 93 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | cD177 antigen measurement | 1.45e-03 | 18 | 93 | 2 | EFO_0021866 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 1.45e-03 | 18 | 93 | 2 | EFO_1000649, HP_0000131 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.48e-03 | 71 | 93 | 3 | EFO_0007878, EFO_0007979 | |
| Disease | Brugada syndrome | 1.62e-03 | 19 | 93 | 2 | MONDO_0015263 | |
| Disease | gestational age, birth measurement | 1.98e-03 | 21 | 93 | 2 | EFO_0005112, EFO_0006921 | |
| Disease | peripheral neuropathy, response to antimicrotubule agent | 2.38e-03 | 23 | 93 | 2 | EFO_0003100, EFO_0005260 | |
| Disease | Sarcosine measurement | 2.38e-03 | 23 | 93 | 2 | EFO_0021668 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YRSETSNSIPPPYYT | 201 | Q9UPW8 | |
| PEAYPIPTQTYTREY | 1216 | P55196 | |
| GTILSPGYPEFYPNS | 1076 | Q7Z407 | |
| NGTIYSPGYPDEYPN | 2291 | Q7Z407 | |
| YQLPYYDLVPSDPSI | 426 | P36896 | |
| DDPTISPSYTYYRPG | 416 | P06731 | |
| SPSYTYYRPGVNLSL | 421 | P06731 | |
| APLYQRPGYYSAPQT | 456 | O76090 | |
| YRDPPHSLVPYGYTL | 861 | Q32M45 | |
| SYPYTEPANPGDSYL | 56 | Q92988 | |
| MPVYYYPSGQYPTST | 636 | Q9UBL0 | |
| GQSGLYSPQYISYIP | 701 | Q8WWM7 | |
| PPLVAATPYSSYIPY | 776 | Q8WWM7 | |
| VKSATPYGLYYPSGP | 656 | Q9UPQ7 | |
| YSYPGYPLSPTISLA | 501 | Q8TBY0 | |
| TPYEYPYTLAPATSI | 286 | Q96PU8 | |
| YGLHYEYTIPSDPLP | 891 | Q8TE59 | |
| TVLSRPLYYTAPFYP | 396 | P78411 | |
| VVPPNYSEGTLPYSY | 736 | Q9UN71 | |
| DSPVRYTPYTISPYN | 61 | Q9H4D5 | |
| TYEGNYYGTPKPPSQ | 181 | Q96QZ7 | |
| TTPCYTPYYVAPEVL | 221 | P49137 | |
| TPYYVAPEVLGPEKY | 226 | P49137 | |
| TLEAYYSSPQDLPYP | 441 | P34932 | |
| SYTQVYTPGYSQPPA | 491 | A4FU01 | |
| LSPYYGIKPSDYISG | 981 | Q8WW38 | |
| SVVEYVKGYPPNSPY | 726 | Q5JUK3 | |
| EPAYYSKLSYDQSPP | 5696 | Q5CZC0 | |
| RPSPYAPYILVYAND | 236 | P55107 | |
| YLFPTPSSYPYGALQ | 926 | O15534 | |
| LYELDISFPPSYPYS | 316 | Q14642 | |
| STEPIYLSLPGQSPY | 181 | O00443 | |
| YLSLPGQSPYFSYPL | 186 | O00443 | |
| AYYVYIPLPGSVSDP | 16 | Q6PIU2 | |
| KLQPYYYPTDSIPEY | 2411 | Q96JB1 | |
| PGETYYYISVPTPES | 126 | P52798 | |
| PLYYPGSNLSALPLY | 251 | A2RU54 | |
| DAGYITSPGYPQDYP | 36 | O60462 | |
| YTEFVPQIPGYQTYP | 626 | Q86TG7 | |
| SYPYLLSSPSYPQEL | 401 | O75023 | |
| PGPKDPAELTYYTLY | 1121 | Q6ZVL6 | |
| PPNYSQGTLPYSYNL | 736 | Q9Y5G0 | |
| PTYSERTLPYSYNPC | 741 | Q9Y5G1 | |
| KNYGVIIPYPPSNRY | 756 | Q96F07 | |
| LYYRPVNTVPSYPGN | 51 | Q6MZM9 | |
| GPSGYIISPNYPKQY | 2926 | O60494 | |
| TYPPYVPEYSSGLFP | 221 | P23771 | |
| AELQYLPPPESQYGY | 216 | Q9HDB9 | |
| PSYGPSQYYPLGQSE | 91 | P14653 | |
| PDFIPSQPEGVYLYS | 91 | P42357 | |
| YIYGPIESTIYPISG | 346 | P15088 | |
| QLCPATATYYTPLYP | 36 | Q14209 | |
| TATYYTPLYPQTAPP | 41 | Q14209 | |
| PYPVTTTVGLFYPYN | 191 | P16671 | |
| YPYSVPLETLPGFQE | 471 | P54257 | |
| DPTAPPYDSIQIYGY | 731 | P55287 | |
| ESYIYNVLYEVPLPP | 241 | Q6IQ26 | |
| YIPELEYGYVQPSVP | 271 | Q9BXR6 | |
| YPYSAQVPPVREVSY | 61 | O43248 | |
| DPSVPPYDSLQTYAY | 726 | Q13634 | |
| SSQLGTYPYYTPTGE | 76 | Q12794 | |
| PLALQDYTPSYGLAP | 886 | Q9NRM1 | |
| PTAPPYDSIQIYGYE | 736 | P55286 | |
| DYLTPDFPSLSYPNY | 61 | Q6UWR7 | |
| GPDLPSIYPSFTYYR | 331 | Q00888 | |
| TGYIESPNYPGDYPA | 806 | Q8IWY4 | |
| PYNVYITVAYPPDTD | 206 | Q06136 | |
| SAPPTEGVYVYGLYL | 4526 | Q8TE73 | |
| GIPLFETQPTYAPLY | 326 | Q15648 | |
| TVPTYRAPGTPTYSY | 176 | A1KXE4 | |
| IVPPYNYSYELVLPS | 706 | Q9BZA8 | |
| SPYYDNVRPLSYPDS | 81 | P61587 | |
| PGSPPRYLLNYYSDS | 61 | A0A075B6I7 | |
| YNTISYKPLPSSNPY | 76 | Q9Y3Y4 | |
| GFPDSVSPDYLPYQL | 81 | Q96GQ5 | |
| LQPLIFYPGYYPDDN | 456 | Q9GZV3 | |
| YPPYNITVIGPYSIF | 3776 | O75445 | |
| STPPYLVYLKSDYLP | 26 | Q8IYP2 | |
| TPDYIAPEIIAYQPY | 501 | P17252 | |
| RSVGYSYPSLPPGYQ | 286 | O95486 | |
| SYYPEAGEVYSPVTP | 16 | P55318 | |
| LSPTPGYPSQYQLYA | 1591 | O75376 | |
| TPVAYYPGPATQLYL | 621 | Q9H6T0 | |
| TPSPYGLSYPQGYSL | 686 | Q17R89 | |
| SGRLVIPAYTYYIPS | 171 | Q9UQ49 | |
| TYRPVTYQSLYSGAP | 321 | O75333 | |
| EPYYQPPYTLVLELT | 141 | Q3ZCQ8 | |
| APYTGYSPYGSELPA | 466 | Q5D1E8 | |
| LPYYTGVPGLPSTFQ | 911 | Q14157 | |
| KGLPTYLSYSNTYPG | 121 | Q8N443 | |
| LTVVALPPGYYLYSQ | 81 | Q96B77 | |
| LAGGPKPYSPYDSQY | 96 | Q9NPH0 | |
| YSDDTPLPTPSYKYN | 261 | Q92620 | |
| PPSYYSIFNYGRTPT | 251 | Q8WVE6 | |
| PYTGQIYQPTQAYTP | 61 | Q969M3 | |
| LPPLTNGYPSSISVY | 66 | Q9BZ95 | |
| FLGAQYPYSVTPPSL | 1556 | A7E2V4 | |
| PLPVQLPASYSYSYS | 291 | Q9BXU3 | |
| SLYSPQTPAYIRSYP | 406 | Q9ULT6 | |
| TFPLPDGYSSLAYVP | 611 | Q14139 | |
| LYGPDLPSIYPSFTY | 236 | Q15238 | |
| TLTAYYQPLEGTPPY | 486 | Q9HBA0 | |
| YQPLEGTPPYPYRTT | 491 | Q9HBA0 | |
| LSSYYPPSIGFPYSL | 56 | Q9BYJ9 | |
| LSLEFPSGYPYNAPT | 81 | O00762 | |
| PSGYPYNAPTVKFLT | 86 | O00762 | |
| EYLKPQYSLPAPSYF | 686 | O75132 |